Upsher-Smith gets 'tentative' OK from FDA for testosterone gel
This article was originally published in Scrip
Executive Summary
Privately held specialty pharma Upsher-Smith said the US FDA has given a "tentative" approval of the firm's new drug application for Vogelxo, a testosterone topical gel.